First, the prognosis of CPFE and IPF combined with LC was significantly worse, which may be related to more explosive systemic inflammation, lower EGFR mutation rate, fewer treatment options, and increased risk of treatment-induced AE. Here, EGFR is linked to idiopathic pulmonary fibrosis.